Breast lumps medical therapy: Difference between revisions
No edit summary |
|||
Line 51: | Line 51: | ||
**Considered as BI-RADS 4 or 5, then core needle biopsy is required. | **Considered as BI-RADS 4 or 5, then core needle biopsy is required. | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | A01 | | | | | |A01=Women age > 40 years}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | | | | | | B01 | | | | | |B01=Mammographic findings}} | |||
{{familytree | | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|-|.|}} | |||
{{familytree | | C01 | | C02 | | C03 | | C04 | | | C05 | |C01=Negative|C02=Fatty tissue|C03=Benign|C04=Probably benign|C05=Suspicious }} | |||
{{familytree | | |!| | | |!| | | |!| | | |!| | | | |!| }} | |||
{{familytree | | C06 | | C07 | | C08 | | C09 | | | C010 |C06=Ultrasound|C07=BI-RADS 1, then clinical follow-up|C08=BI-RADS 2, then clinical follow-up|C09=Ultrasound|C010=Ultrasound for biopsy plan determination}} | |||
{{familytree | | |!| | | | | | | | | | | |!| | | | |!| |}} | |||
{{familytree | | |!| | | | | | | | | | | |!| | | | C019|C019=BI-RADS 4 or 5, then core needle biopsy}} | |||
{{familytree | | |!| | | | | | | | | | | |)|-|-|-|v|-|-|-|v|-|-|-|.|}} | |||
{{familytree | | |!| | | | | | | | | | | |!| | | |!| | | |!| | | |!|}} | |||
{{familytree | | |!| | | | | | | | | | | C011| | C012| | C013| | C014|C011=Negative|C012=Benign|C013=Probably benign|C014=Suspicious}} | |||
{{familytree | | |!| | | | | | | | | | | |!| | | |!| | | |!| | | |!|}} | |||
{{familytree | | |!| | | | | | | | | | | C015| | C016| | C017| | C018|C015=BI-RADS 3, then mammographic short interval follow-up|C016=BI-RADS 2, then clinical follow-up|C017=BI-RADS 3, then ultrasound short interval follow-up|C018=BI-RADS 4 or 5, then core needle biopsy}} | |||
{{familytree | | |)|-|-|-|v|-|-|-|v|-|-|-|.|}} | |||
{{familytree | | |!| | | |!| | | |!| | | |!|}} | |||
{{familytree | | D01 | | D02 | | D03 | | D04 | | |D01=Negative results|D02=Benign|D03=Probably benign|D04=Suspicious}} | |||
{{familytree | | |!| | | |!| | | |!| | | |!| | | | }} | |||
{{familytree | | E01 | | E02 | | E03 | | E04 | | |E01=BI-RADS 1, then clinical follow-up|E02=BI-RADS 2, then clinical follow-up|E03=BI-RADS 3, then ultrasound short interval follow-up|E04= BI-RADS 4 or 5, then core needle biopsy}} | |||
{{familytree/end}} | |||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | A01 | | | | | |A01=Women age < 40 years}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | | | | | | B01 | | | | | |B01=Targeted ultrasound}} | |||
{{familytree | | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.|}} | |||
{{familytree | | C01 | | C02 | | | | | | C03 | | C04 | | | |C01=Negative|C02=Benign|C03=Probably benign|C04=Suspicious}} | |||
{{familytree | | |!| | | | | |}} | |||
{{familytree | | |)|-|-|-|-|.| |}} | |||
{{familytree | | |!| | | | |!|}} | |||
{{familytree | | C05 | | | C06|C05=BI-RADS 1, then clinical follow-up|C06=Perform diagnostic mammography}} | |||
{{familytree | | | | | | | |!| }} | |||
{{familytree/end}} | |||
==References== | ==References== |
Revision as of 16:38, 8 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps medical therapy On the Web |
American Roentgen Ray Society Images of Breast lumps medical therapy |
Risk calculators and risk factors for Breast lumps medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Management and medical therapy of breast lumps depends on women's age (age> 40 or age <40) and mammography results in women aged > 40 years. In women aged > 40 years; no further evaluation is needed in case of clearly benign mass in mammography; however, ultrasound imaging is required for the rest of the findings mammography. Approach to breast lumps in women >40 years is depended on breast imaging reporting and data systems (BI-RADS) stages. Medical therapy of breast lumps in women< 40 years is depended on ultrasound results and BI-RADS categories.
Breast lumps medical therapy
Management of breast lumps:
- women aged >40 years with palpable mass:[1]
- Diagnostic mammography is considered as the first step.
- If the last screening test is related to more than previous 6 months, both breast mammography is required to rule out occult malignancy.
- No further evaluation is needed in case of clearly benign mass in mammography.
- Ultrasound imaging is required for the rest of cases appeared in mammography.
- Stereotactic biopsy is recommended in negative ultrasound findings addition to suspicious mammographic results.
- Women aged< 40 years with palpable mass:[2][3]
- Ultrasound or mammography is suggested for initial management of women aged between 30 to 39 years.
- Ultrasound is the first step for women< 30 years presenting with palpable mass.
Approach to breast lumps in women aged >40 years based on mammographic results:[1]
- If mammographic results become negative, the next step is targeted ultrasound.
- Negative ultrasound results considered as breast imaging reporting and data system (BI-RADS) 1, then clinical follow-up is needed.
- Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is needed.
- Probably benign results considered as BI-RADS 3, then ultrasound short interval follow-up is needed.
- Suspicious ultrasound results considered as BI-RADS 4 or 5, then core-needle biopsy is needed.
- If mammographic results show only fatty tissue:
- Considered as BI-RADS 1, then clinical follow-up is needed.
- If mammographic results show benign mass:
- Considered as BI-RADS 2, then clinical follow-up
- If mammographic results are in favor of probably benign lumps, the next step is targeted ultrasound.
- Negative ultrasound results considered as BI-RADS 3, then mammographic short interval follow-up is required.
- Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is required.
- Probably benign ultrasound results considered as BI-RADS 3, then ultrasound short interval follow-up.
- Suspicious ultrasound results is considered as BI-RADS 4 or 5, then core needle biopsy is required.
- If mammographic result is in favor of suspicious lesion, the next step is ultrasound to determine biopsy plan.
- Considered as BI-RADS 4 or 5, then core needle biopsy is required.
Approach to breast lumps in women aged <40 years based on targeted ultrasound findings:[1]
- If ultrasound results become negative, there are two approaches:
- Considered as BI-RADS 1, then clinical follow-up is required.
- Perform diagnostic mammography:
- Negative results are in favor of BI-RADS 1, then clinical follow-up is required.
- Benign results are considered as BI-RADS 2, then clinical follow-up is required.
- Probably benign results considered as BI-RADS 3, Mammographic short interval follow-up is required.
- Suspicious results considered as BI-RADS 4 or 5, then core needle biopsy is required.
- If ultrasound results show benign findings:
- Considered as BI-RADS 2, then clinical follow-up is required.
- If ultrasound results show probably benign findings:
- Considered as BI-RADS 3, then short interval follow-up is required.
- If ultrasound results become suspicious:
- Considered as BI-RADS 4 or 5, then core needle biopsy is required.
Women age > 40 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mammographic findings | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | Fatty tissue | Benign | Probably benign | Suspicious | |||||||||||||||||||||||||||||||||||||||||||||||||||
Ultrasound | BI-RADS 1, then clinical follow-up | BI-RADS 2, then clinical follow-up | Ultrasound | Ultrasound for biopsy plan determination | |||||||||||||||||||||||||||||||||||||||||||||||||||
BI-RADS 4 or 5, then core needle biopsy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | Benign | Probably benign | Suspicious | ||||||||||||||||||||||||||||||||||||||||||||||||||||
BI-RADS 3, then mammographic short interval follow-up | BI-RADS 2, then clinical follow-up | BI-RADS 3, then ultrasound short interval follow-up | BI-RADS 4 or 5, then core needle biopsy | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative results | Benign | Probably benign | Suspicious | ||||||||||||||||||||||||||||||||||||||||||||||||||||
BI-RADS 1, then clinical follow-up | BI-RADS 2, then clinical follow-up | BI-RADS 3, then ultrasound short interval follow-up | BI-RADS 4 or 5, then core needle biopsy | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Women age < 40 years | |||||||||||||||||||||||||||||||||||||||||||||
Targeted ultrasound | |||||||||||||||||||||||||||||||||||||||||||||
Negative | Benign | Probably benign | Suspicious | ||||||||||||||||||||||||||||||||||||||||||
BI-RADS 1, then clinical follow-up | Perform diagnostic mammography | ||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ 1.0 1.1 1.2 Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D'Orsi C; et al. (2016). "ACR Appropriateness Criteria Palpable Breast Masses". J Am Coll Radiol. 13 (11S): e31–e42. doi:10.1016/j.jacr.2016.09.022. PMID 27814822.
- ↑ Lehman CD, Lee AY, Lee CI (2014). "Imaging management of palpable breast abnormalities". AJR Am J Roentgenol. 203 (5): 1142–53. doi:10.2214/AJR.14.12725. PMID 25341156.
- ↑ Loving VA, DeMartini WB, Eby PR, Gutierrez RL, Peacock S, Lehman CD (2010). "Targeted ultrasound in women younger than 30 years with focal breast signs or symptoms: outcomes analyses and management implications". AJR Am J Roentgenol. 195 (6): 1472–7. doi:10.2214/AJR.10.4396. PMID 21098212.